Ignite Creation Date:
2024-05-06 @ 3:50 PM
Last Modification Date:
2024-10-26 @ 1:58 PM
Study NCT ID:
NCT04777981
Status:
UNKNOWN
Last Update Posted:
2022-02-22
First Post:
2021-02-25
Brief Title:
CBDRA60 to Prevent or Reduce Symptoms of COVID-19 and Prevention of Post-Acute Sequelae of SARS-CoV-2 Infection PASC
Sponsor:
Organization:
Anewsha Therapeutics Inc